FDA approves oral combination of decitabine and cedazuridine for myelodysplastic syndromes

Hematology / Oncology News Burst

Source: FDA Center for Drug Evaluation and Research - What's New - July 7, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news